|
KMID : 1191520190240010019
|
|
Journal of Korean Traditional Oncology
2019 Volume.24 No. 1 p.19 ~ p.28
|
|
|
A Case Report of Metastatic Breast Cancer Patient Treated with Integrative Cancer Treatment
|
|
Ha Su-Jeung
Lee Sung-Cheol
Park So-Jung
Jun Hyung-Joon
Lee Yeon-Weol
Cho Chong-Kwan
Yoo Hwa-Seung
|
|
|
Abstract
|
|
|
Objective : The purpose of this study is to report and observe effects of Integrative Cancer Treatment (ICT) on metastatic breast cancer patient.
Method : A left breast cancer patient diagnosed with recurrence on liver and bones April 2018. The patient had received paclitaxel chemotherapy for two months and discontinued it because of tumor progression and side effects. The patient has been treated with ICT since March 2018 and has been taking capecitabine since October 2018. The clinical outcomes were measured by computed tomography, laboratory findings including tumor markers (CEA, CA15-3). The clinical outcomes were measured by computed tomography, laboratory findings including tumor markers (CEA, CA15-3), liver function test (AST, ALT), Eastern Cooperative Oncology Group performance status (ECOG PS), and numeric rating scales (NRS).
Results : After the ICT, tumor size was partially decreased accompanying by reducing the levels of tumor markers. Major clinical symptoms induced by paclitaxel chemotherapy were improved. There were no severe adverse events induced by ICT based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 5.0.
Conclusion : This case suggests that ICT may have synergistic effect for the treatment of metastatic breast cancer patient in conjunction with capecitabine.
|
|
|
KEYWORD
|
|
|
Breast cancer, Capecitabine, Integrative Cancer Treatment, Herbal medicine, Quality of Life
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|